Myofascial Pain Syndrome - Lower Back

0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

AM-Pharma
AM-PharmaNetherlands - Utrecht
1 program
Active SonodynN/A1 trial
Active Trials
NCT05851326RecruitingEst. Oct 2025

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
AM-PharmaActive Sonodyn

Clinical Trials (1)

NCT05851326AM-PharmaActive Sonodyn

Low-Energy Ultrasound, Electrical and Magnetic Field Stimulation in Therapy-Resistant Myofascial Pain Syndrome

Start: May 2023Est. completion: Oct 2025
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials
1 companies competing in this space